Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease.
Scand J Rheumatol
; 46(3): 247-252, 2017 05.
Article
in En
| MEDLINE
| ID: mdl-27900875
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
Lung Diseases, Interstitial
/
Rituximab
/
Immunologic Factors
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Scand J Rheumatol
Year:
2017
Type:
Article
Affiliation country:
Japan